ArticlePlastic and reconstructive surgery. Global open2025
Aesthetic Breast Reconstruction With De-epidermized Deep Inferior Epigastric Artery Perforator Flap and Thoracoabdominal Advancement Flap.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Donor-site Seroma in Deep Inferior Epigastric Perforator Flap Breast Reconstruction: A Pooled Analysis.Plastic and reconstructive surgery. Global open · 2026Article
- Cosmetic Principles and Contemporary Techniques: Achieving Aesthetic Outcomes in DIEP Flap Breast Reconstruction.Journal of clinical medicine · 2026Review
- Creating Engineered NAC Flaps Using in Vivo Revascularization: A Proof-Of-Concept Study.Stem cell reviews and reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Most regard the deep inferior epigastric artery perforator (DIEP) flap as the gold standard in autologous breast reconstruction, with good breast aesthetics achieved and low donor site morbidity. Mojallal et al introduced a new surgical protocol to enhance results for both the breast and abdomen further. This study presented the first clinical series of patients benefitting from breast reconstruction based on a combination of a DIEP flap and a thoracoabdominal advancement flap (TAAF). Methods: A retrospective study was conducted at our institution from January 2013 to October 2020. We included all 100 consecutive patients in whom the technique was used. Patients' characteristics, types of surgical procedures, and outcomes were recorded. Patient satisfaction and quality of life were measured with BREAST-Q 2.0 reconstructive modules. Results: A total of 101 DIEP flaps and 100 TAAFs were included. The mean follow-up was 26.9 months. In all cases, the DIEP skin paddle could be removed, and the abdominal scar was concealed under the patient's undergarments. No TAAF necrosis or major abdominal complications were recorded. Four DIEP flap failures were successfully treated with implants, lipofilling, or muscle-sparing latissimus dorsi flaps while preserving the benefit of the TAAF. Breast and abdominal aesthetics were satisfying, with high BREAST-Q scores. Conclusions: The TAAF combined with the DIEP flap is a reliable technique for delayed unilateral breast reconstruction. Excellent aesthetic results and high patient satisfaction can be achieved without compromising safety.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.